Dividend Challenger Highlights: Week Of July 19

10:29am, Saturday, 18'th Jul 2020
A weekly summary of dividend activity for Dividend Challengers. Companies which changed their dividends.
Harbor Investment Advisory LLC grew its position in Quest Diagnostics Inc (NYSE:DGX) by 251.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchan
Exchange Traded Concepts LLC boosted its position in Quest Diagnostics Inc (NYSE:DGX) by 6,231.1% in the second quarter, according to the company in its most recent Form 13F filing with the Securities
The breathing space afforded by lockdowns in the spring has been squandered, with new cases running at five times the rate of the whole of Europe. Things will only get worse, experts warn
Investors are braced for a barrage of earnings news, and the debate in Congress around fiscal stimulus may also be an important catalyst.
The United States shattered its daily coronavirus case record with more than 73,000 new cases, adding to the exponential growth of the outbreak in the top global hotspot, as political divisions widen
Looking at this demand for testing, Quest Diagnostics (DGX) has significantly picked up capacity to perform molecular diagnostic tests a day.
Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
MERIAN GLOBAL INVESTORS UK Ltd acquired a new position in Quest Diagnostics Inc (NYSE:DGX) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fi
CENTRAL TRUST Co boosted its holdings in Quest Diagnostics Inc (NYSE:DGX) by 5.5% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,604 shares of t
When people first started showing signs of coronavirus in the U.S. in March they were told they needed special permission to get tested. If they didn’t fit...
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 16) AC Immune SA (NASDAQ: ACIU...
Quest Diagnostics (DGX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Does Quest Diagnostics (DGX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Quest Diagnostics (NYSE:DGX) was upgraded by Bank of America from a “neutral” rating to a “buy” rating in a research report issued to clients and investors on Tuesday, MarketBeat.com reports.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE